Systemic oxidative stress, as measured by urinary allantoin and F2-isoprostanes, is not increased in Down syndrome

Autor: Tolun, Adviye A., Scarbrough, Peter M., Zhang, Haoyue, McKillop, Jane-Ann, Wang, Frances, Kishnani, Priya S., Millington, David S., Young, Sarah P., Il’yasova, Dora
Zdroj: In Annals of Epidemiology December 2012 22(12):892-894
Databáze: ScienceDirect